ArticleBMC health services research2026
Development of a patient journey map for diabetic retinopathy: exploring evidence from qualitative research.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization has emphasized people-centered health, shifting focus from disease to patient needs. Patient Journey Mapping has emerged as a valuable methodological approach to support healthcare and nursing management by visualizing patient experiences and identifying service improvement opportunities. Despite extensive clinical research on diabetic retinopathy (DR), the phases and dimensions of its healthcare management process remain poorly understood. This study aimed to: (a) synthesize existing qualitative evidence on the experiences, emotions, and healthcare needs of persons with DR across screening, perioperative, and extended treatment stages; (b) conduct semi-structured interviews to contextualize and enrich the synthesized evidence; and (c) develop an integrated Patient Journey Map to inform tailored healthcare interventions.
methodsThis study employed a two-phase qualitative evidence mapping and interview design. Phase 1 comprised a narrative literature review with systematic search to map existing qualitative evidence, with data analyzed using thematic synthesis. Phase 2 involved semi-structured interviews with 13 persons with DR at a Chinese university hospital, with data analyzed using qualitative content analysis. Literature and interview findings were integrated through triangulation to construct a comprehensive Patient Journey Map. Quality was assessed using CASP and GRADE-CERQual; reporting followed ENTREQ guidelines.
resultsTwenty-five studies were included, describing patient experiences across screening, perioperative, and post-acute care phases, forming a preliminary framework. Interviews with 13 persons with DR enriched these findings and established a complete journey trajectory.
conclusionsThe proposed Patient Journey Map visually illustrates patient experiences and behaviors across the care continuum. This evidence provides a theoretical foundation for developing tailored diabetes care recommendations based on individual needs. Patient Journey Mapping contributes to improving healthcare management processes and supports healthcare managers in optimizing service delivery. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.